Simpson Thacher is representing Patricia Industries and Advanced Instruments in connection with Advanced Instruments’ signed agreement to acquire Solentim for approximately $240 million. The closing of the transaction is expected during the third quarter of 2021.
Solentim is the trusted global leader in workflows for antibody and cell-based therapies. Solentim’s assurance rich technologies enable the isolation, growth and characterization of high value cells while its data-driven platform enables smarter decision making earlier in the cell line development process.
Patricia Industries is a long-term owner that invests in companies and works to develop each company to its full potential. Patricia Industries is a part of the industrial holding company Investor AB, whose main owner is the Wallenberg Foundations.
Advanced Instruments is the leading global provider of osmolality testing instrumentation and consumables for the clinical, biopharmaceutical, and food and beverage markets. With a strong brand reputation and deep customer relationships, it is recognized as the global authority on osmolality testing, and its products are the standard within each of its core markets. Advanced Instruments is based in Norwood, Massachusetts and is majority owned by Patricia Industries, a part of Investor AB.
The Simpson Thacher team includes Derek Baird, Michael T. Holick, Surya Banerjee, Carlo Pia and Jess Yoon (M&A); Yash Rupal and Ellie Verran (Tax); David Vann, Ross Ferguson, Sara Razi and Kelly Karapetyan (Regulatory); and Vanessa Burrows (Healthcare).